T. Rowe Price Associates’s Omeros OMER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Buy |
107,293
+11,548
| +12% | +$136K | ﹤0.01% | 2096 |
|
|
2025
Q4 | $1.64M | Buy |
95,745
+6,217
| +7% | +$53.5K | ﹤0.01% | 1846 |
|
|
2025
Q3 | $368K | Buy |
89,528
+12,737
| +17% | +$50.5K | ﹤0.01% | 2505 |
|
|
2025
Q2 | $231K | Buy |
76,791
+1,287
| +2% | +$6.41K | ﹤0.01% | 2651 |
|
|
2025
Q1 | $621K | Buy |
75,504
+35,922
| +91% | +$317K | ﹤0.01% | 2171 |
|
|
2024
Q4 | $392K | Buy |
39,582
+4,401
| +13% | +$30.2K | ﹤0.01% | 2390 |
|
|
2024
Q3 | $140K | Hold |
35,181
| – | – | ﹤0.01% | 2762 |
|
|
2024
Q2 | $143K | Hold |
35,181
| – | – | ﹤0.01% | 2679 |
|
|
2024
Q1 | $122K | Buy |
35,181
+2,248
| +7% | +$8.55K | ﹤0.01% | 2743 |
|
|
2023
Q4 | $108K | Buy |
32,933
+1,705
| +5% | +$3.6K | ﹤0.01% | 2709 |
|
|
2023
Q3 | $92K | Buy |
31,228
+1,278
| +4% | +$5.13K | ﹤0.01% | 2686 |
|
|
2023
Q2 | $163K | Buy |
29,950
+7,750
| +35% | +$45.3K | ﹤0.01% | 2590 |
|
|
2023
Q1 | $104K | Sell |
22,200
-8,400
| -27% | -$30.3K | ﹤0.01% | 2682 |
|
|
2022
Q4 | $69K | Buy |
30,600
+13,000
| +74% | +$35.9K | ﹤0.01% | 2771 |
|
|
2022
Q3 | $56K | Hold |
17,600
| – | – | ﹤0.01% | 2819 |
|
|
2022
Q2 | $48K | Sell |
17,600
-5,255
| -23% | -$17.8K | ﹤0.01% | 2866 |
|
|
2022
Q1 | $137K | Buy |
22,855
+8,300
| +57% | +$51.8K | ﹤0.01% | 2796 |
|
|
2021
Q4 | $94K | Sell |
14,555
-18,100
| -55% | -$131K | ﹤0.01% | 2884 |
|
|
2021
Q3 | $450K | Hold |
32,655
| – | – | ﹤0.01% | 2425 |
|
|
2021
Q2 | $485K | Sell |
32,655
-1,391
| -4% | -$23.3K | ﹤0.01% | 2404 |
|
|
2021
Q1 | $606K | Buy |
34,046
+15
| +0% | +$292 | ﹤0.01% | 2282 |
|
|
2020
Q4 | $486K | Buy |
34,031
+12,813
| +60% | +$157K | ﹤0.01% | 2253 |
|
|
2020
Q3 | $214K | Buy |
21,218
+432
| +2% | +$5.56K | ﹤0.01% | 2402 |
|
|
2020
Q2 | $306K | Buy |
20,786
+263
| +1% | +$3.93K | ﹤0.01% | 2239 |
|
|
2020
Q1 | $274K | Buy |
20,523
+542
| +3% | +$7.21K | ﹤0.01% | 2221 |
|
|
2019
Q4 | $282K | Buy |
19,981
+1,885
| +10% | +$27.6K | ﹤0.01% | 2335 |
|
|
2019
Q3 | $296K | Buy |
18,096
+231
| +1% | +$3.96K | ﹤0.01% | 2286 |
|
|
2019
Q2 | $280K | Buy |
17,865
+146
| +0.8% | +$2.62K | ﹤0.01% | 2322 |
|
|
2019
Q1 | $308K | Buy |
+17,719
| New | +$255K | ﹤0.01% | 2282 |
|
|
2018
Q3 | – | Sell |
-16,851
| Closed | -$306K | – | 2597 |
|
|
2018
Q2 | $306K | Buy |
16,851
+5,849
| +53% | +$101K | ﹤0.01% | 2341 |
|
|
2018
Q1 | $123K | Buy |
11,002
+89
| +0.8% | +$1.25K | ﹤0.01% | 2481 |
|
|
2017
Q4 | $212K | Sell |
10,913
-1,700
| -13% | -$31.9K | ﹤0.01% | 2409 |
|
|
2017
Q3 | $273K | Hold |
12,613
| – | – | ﹤0.01% | 2313 |
|
|
2017
Q2 | $251K | Sell |
12,613
-300
| -2% | -$5.24K | ﹤0.01% | 2299 |
|
|
2017
Q1 | $195K | Buy |
12,913
+13
| +0.1% | +$142 | ﹤0.01% | 2399 |
|
|
2016
Q4 | $128K | Hold |
12,900
| – | – | ﹤0.01% | 2445 |
|
|
2016
Q3 | $144K | Buy |
+12,900
| New | +$147K | ﹤0.01% | 2395 |
|
Other funds holding OMER
ISL
VCM
VPM
T. Rowe Price Associates's OMER Position: Q1 2026 in Review
T. Rowe Price Associates increased its Omeros (OMER) stake by 12% in Q1 2026, buying an estimated $136K and bringing the position to 107,293 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.
T. Rowe Price Associates first reported a position in OMER in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.64M in Q4 2025. 161 funds tracked by Wall St. Rank hold OMER as of Q1 2026.
- T. Rowe Price Associates held 107,293 shares of Omeros worth $1.13M as of Q1 2026.
- T. Rowe Price Associates bought 11,548 Omeros shares in Q1 2026, an estimated $136K.
- Omeros made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2096 holding.
- T. Rowe Price Associates first reported a position in Omeros in Q3 2016 and has held it in 37 quarters since.
- T. Rowe Price Associates's Omeros position peaked at $1.64M in Q4 2025.
- 161 funds tracked by Wall St. Rank held Omeros as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.